Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial.

Husebo BS, Ballard C, Sandvik R, Nilsen OB, Aarsland D.

BMJ. 2011 Jul 15;343:d4065. doi: 10.1136/bmj.d4065.

2.

Determining the minimum clinically important differences for outcomes in the DOMINO trial.

Howard R, Phillips P, Johnson T, O'Brien J, Sheehan B, Lindesay J, Bentham P, Burns A, Ballard C, Holmes C, McKeith I, Barber R, Dening T, Ritchie C, Jones R, Baldwin A, Passmore P, Findlay D, Hughes A, Macharouthu A, Banerjee S, Jones R, Knapp M, Brown RG, Jacoby R, Adams J, Griffin M, Gray R.

Int J Geriatr Psychiatry. 2011 Aug;26(8):812-7. doi: 10.1002/gps.2607. Epub 2010 Sep 16.

PMID:
20848576
3.

Assessing neuropsychiatric symptoms in nursing home patients with dementia: reliability and Reliable Change Index of the Neuropsychiatric Inventory and the Cohen-Mansfield Agitation Inventory.

Zuidema SU, Buursema AL, Gerritsen MG, Oosterwal KC, Smits MM, Koopmans RT, de Jonghe JF.

Int J Geriatr Psychiatry. 2011 Feb;26(2):127-34. doi: 10.1002/gps.2499.

PMID:
20690131
4.

Atypical antipsychotics for the treatment of behavioral and psychological symptoms in dementia, with a particular focus on longer term outcomes and mortality.

Ballard C, Creese B, Corbett A, Aarsland D.

Expert Opin Drug Saf. 2011 Jan;10(1):35-43. doi: 10.1517/14740338.2010.506711. Epub 2010 Aug 5. Review.

PMID:
20684745
5.

Prevalence of neuropsychiatric symptoms and their association with functional limitations in older adults in the United States: the aging, demographics, and memory study.

Okura T, Plassman BL, Steffens DC, Llewellyn DJ, Potter GG, Langa KM.

J Am Geriatr Soc. 2010 Feb;58(2):330-7. doi: 10.1111/j.1532-5415.2009.02680.x. Epub 2010 Jan 26.

6.
7.

Management of agitation and aggression associated with Alzheimer's disease: controversies and possible solutions.

Ballard C, Corbett A, Chitramohan R, Aarsland D.

Curr Opin Psychiatry. 2009 Nov;22(6):532-40. doi: 10.1097/YCO.0b013e32833111f9. Review.

PMID:
19696673
8.

Prevalence of stress, anxiety and depression in with Alzheimer caregivers.

Ferrara M, Langiano E, Di Brango T, De Vito E, Di Cioccio L, Bauco C.

Health Qual Life Outcomes. 2008 Nov 6;6:93. doi: 10.1186/1477-7525-6-93.

9.

Patient and caregiver perspectives of quality of life in dementia. An investigation of the relationship to behavioural and psychological symptoms in dementia.

Hurt C, Bhattacharyya S, Burns A, Camus V, Liperoti R, Marriott A, Nobili F, Robert P, Tsolaki M, Vellas B, Verhey F, Byrne EJ.

Dement Geriatr Cogn Disord. 2008;26(2):138-46. doi: 10.1159/000149584. Epub 2008 Aug 4.

10.
11.
12.

Efficacy of memantine on behavioral and psychological symptoms related to dementia: a systematic meta-analysis.

Maidment ID, Fox CG, Boustani M, Rodriguez J, Brown RC, Katona CL.

Ann Pharmacother. 2008 Jan;42(1):32-8. Epub 2007 Dec 4.

PMID:
18056833
13.

Donepezil for the treatment of agitation in Alzheimer's disease.

Howard RJ, Juszczak E, Ballard CG, Bentham P, Brown RG, Bullock R, Burns AS, Holmes C, Jacoby R, Johnson T, Knapp M, Lindesay J, O'Brien JT, Wilcock G, Katona C, Jones RW, DeCesare J, Rodger M; CALM-AD Trial Group.

N Engl J Med. 2007 Oct 4;357(14):1382-92.

14.

Neuroleptic drugs in dementia: benefits and harm.

Ballard C, Howard R.

Nat Rev Neurosci. 2006 Jun;7(6):492-500. Review.

PMID:
16715057
15.

Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial.

Fossey J, Ballard C, Juszczak E, James I, Alder N, Jacoby R, Howard R.

BMJ. 2006 Apr 1;332(7544):756-61. Epub 2006 Mar 16. Erratum in: BMJ. 2006 Apr 1;332(7544):61.

16.

Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials.

Schneider LS, Dagerman K, Insel PS.

Am J Geriatr Psychiatry. 2006 Mar;14(3):191-210.

PMID:
16505124
17.

Global prevalence of dementia: a Delphi consensus study.

Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M; Alzheimer's Disease International.

Lancet. 2005 Dec 17;366(9503):2112-7.

18.

Persistence of and changes in neuropsychiatric symptoms in Alzheimer disease over 6 months: the LASER-AD study.

Ryu SH, Katona C, Rive B, Livingston G.

Am J Geriatr Psychiatry. 2005 Nov;13(11):976-83.

PMID:
16286441
19.

Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia.

Livingston G, Johnston K, Katona C, Paton J, Lyketsos CG; Old Age Task Force of the World Federation of Biological Psychiatry.

Am J Psychiatry. 2005 Nov;162(11):1996-2021. Review.

PMID:
16263837
20.

Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial.

Ballard C, Margallo-Lana M, Juszczak E, Douglas S, Swann A, Thomas A, O'Brien J, Everratt A, Sadler S, Maddison C, Lee L, Bannister C, Elvish R, Jacoby R.

BMJ. 2005 Apr 16;330(7496):874. Epub 2005 Feb 18.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk